Your browser doesn't support javascript.
loading
MC1R variants and cutaneous melanoma risk according to histological type, body site, and Breslow thickness: a pooled analysis from the M-SKIP project.
Caini, Saverio; Gandini, Sara; Botta, Francesca; Tagliabue, Elena; Raimondi, Sara; Nagore, Eduardo; Zanna, Ines; Maisonneuve, Patrick; Newton-Bishop, Julia; Polsky, David; Lazovich, DeAnn; Kumar, Rajiv; Kanetsky, Peter A; Hoiom, Veronica; Ghiorzo, Paola; Landi, Maria Teresa; Ribas, Gloria; Menin, Chiara; Stratigos, Alexander J; Palmieri, Giuseppe; Guida, Gabriella; García-Borrón, Jose Carlos; Nan, Hongmei; Little, Julian; Sera, Francesco; Puig, Susana; Fargnoli, Maria Concetta.
Afiliação
  • Caini S; Cancer Risk Factors and Lifestyle Epidemiology Unit, Institute for Cancer Research, Prevention and Clinical Network (ISPRO), Florence.
  • Gandini S; Molecular and Pharmaco-Epidemiology Unit, Department of Molecular Oncology, IEO, European Institute of Oncology IRCCS.
  • Botta F; Department of Statistics and Quantitative Methods, Università degli Studi di Milano-Bicocca.
  • Tagliabue E; Division of Epidemiology and Biostatistics, IEO, European Institute of Oncology IRCCS.
  • Raimondi S; IRCCS MultiMedica, Milan, Italy.
  • Nagore E; Molecular and Pharmaco-Epidemiology Unit, Department of Molecular Oncology, IEO, European Institute of Oncology IRCCS.
  • Zanna I; Department of Dermatology, Instituto Valenciano de Oncologia, Valencia, Spain.
  • Maisonneuve P; Cancer Risk Factors and Lifestyle Epidemiology Unit, Institute for Cancer Research, Prevention and Clinical Network (ISPRO), Florence.
  • Newton-Bishop J; Division of Epidemiology and Biostatistics, IEO, European Institute of Oncology IRCCS.
  • Polsky D; Section of Epidemiology and Biostatistics, Institute of Medical Research at St James's, University of Leeds, Leeds, UK.
  • Lazovich D; The Ronald O. Perelman Department of Dermatology, New York University School of Medicine, NYU Langone Medical Center, New York, New York.
  • Kumar R; Division of Epidemiology and Community Health, University of Minnesota, Minneapolis, Minnesota, USA.
  • Kanetsky PA; Division of Molecular Genetic Epidemiology, German Cancer Research Center, Heidelberg, Germany.
  • Hoiom V; Department of Cancer Epidemiology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida, USA.
  • Ghiorzo P; Department of Oncology and Pathology, Cancer Center, Karolinska Institutet, Stockholm, Sweden.
  • Landi MT; Department of Internal Medicine and Medical Specialties, University of Genoa and Ospedale Policlinico San Martino, Genoa, Italy.
  • Ribas G; Division of Cancer Epidemiology and Genetics, National Cancer Institute, NIH, Bethesda, Maryland, USA.
  • Menin C; Dpdt. Oncologia medica y hematologia, Fundación Investigación Clínico de Valencia Instituto de Investigación Sanitaria- INCLIVA, Valencia, Spain.
  • Stratigos AJ; Immunology and Diagnostic Molecular Oncology Unit, Veneto Institute of Oncology, IOV-IRCCS, Padua, Italy.
  • Palmieri G; Andreas Sygros Hospital, National and Kapodistrian University of Athens, Greece.
  • Guida G; Unit of Cancer Genetics, Istituto di Chimica Biomolecolare, CNR, Sassari.
  • García-Borrón JC; Department of Basic Medical Sciences, Neurosciences and Sense Organs, University of Bari 'A. Moro', Bari, Italy.
  • Nan H; Department of Biochemistry, Molecular Biology and Immunology, University of Murcia and IMIB-Arrixaca, Murcia, Spain.
  • Little J; Department of Epidemiology, Richard M. Fairbanks School of Public Health, Melvin & Bren Simon Cancer Center, Indiana University, Indianapolis, Indiana, USA.
  • Sera F; School of Epidemiology and Public Health, University of Ottawa, Ottawa, Canada.
  • Puig S; Department of Public Health, Environments and Society, London School of Hygiene & Tropical Medicine, London, UK.
  • Fargnoli MC; Melanoma Unit, Dermatology Department, Hospital Clinic Barcelona, Universitat de Barcelona, Institut d'Investigacions Biomèdiques August Pi I Sunyer (IDIBAPS) Spain & CIBER de Enfermedades Raras, Barcelona, Spain.
Melanoma Res ; 30(5): 500-510, 2020 10.
Article em En | MEDLINE | ID: mdl-32898390

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Cutâneas / Receptor Tipo 1 de Melanocortina / Melanoma Idioma: En Ano de publicação: 2020 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Cutâneas / Receptor Tipo 1 de Melanocortina / Melanoma Idioma: En Ano de publicação: 2020 Tipo de documento: Article